| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1657 | 2019 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1466 | 2018 |
| Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells QT Phan, CL Myers, Y Fu, DC Sheppard, MR Yeaman, WH Welch, ... PLoS biology 5 (3), e64, 2007 | 735 | 2007 |
| Tackling the emerging threat of antifungal resistance to human health MC Fisher, A Alastruey-Izquierdo, J Berman, T Bicanic, EM Bignell, ... Nature reviews microbiology 20 (9), 557-571, 2022 | 711 | 2022 |
| Complementary adhesin function in C. albicans biofilm formation CJ Nobile, HA Schneider, JE Nett, DC Sheppard, SG Filler, DR Andes, ... Current biology 18 (14), 1017-1024, 2008 | 468 | 2008 |
| Threats posed by the fungal kingdom to humans, wildlife, and agriculture MC Fisher, SJ Gurr, CA Cuomo, DS Blehert, H Jin, EH Stukenbrock, ... MBio 11 (3), 10.1128/mbio. 00449-20, 2020 | 423 | 2020 |
| Functional and structural diversity in the Als protein family of Candida albicans DC Sheppard, MR Yeaman, WH Welch, QT Phan, Y Fu, AS Ibrahim, ... Journal of Biological Chemistry 279 (29), 30480-30489, 2004 | 388 | 2004 |
| Fungal invasion of normally non-phagocytic host cells SG Filler, DC Sheppard PLoS pathogens 2 (12), e129, 2006 | 384 | 2006 |
| International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus PE Verweij, M Ananda-Rajah, D Andes, MC Arendrup, RJ Brüggemann, ... Drug Resistance Updates 21, 30-40, 2015 | 335 | 2015 |
| The role of mast cells in the defence against pathogens M Urb, DC Sheppard PLoS pathogens 8 (4), e1002619, 2012 | 332 | 2012 |
| Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms P Baker, PJ Hill, BD Snarr, N Alnabelseya, MJ Pestrak, MJ Lee, ... Science advances 2 (5), e1501632, 2016 | 326 | 2016 |
| Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway Y Fu, AS Ibrahim, DC Sheppard, YC Chen, SW French, JE Cutler, ... Molecular microbiology 44 (1), 61-72, 2002 | 315 | 2002 |
| Aspergillus Galactosaminogalactan Mediates Adherence to Host Constituents and Conceals Hyphal β-Glucan from the Immune System FN Gravelat, A Beauvais, H Liu, MJ Lee, BD Snarr, D Chen, W Xu, ... PLoS pathogens 9 (8), e1003575, 2013 | 312 | 2013 |
| Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis M Laverdiere, RG Lalonde, JG Baril, DC Sheppard, S Park, DS Perlin Journal of Antimicrobial Chemotherapy 57 (4), 705-708, 2006 | 257 | 2006 |
| Role of the fungal Ras‐protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis H Park, CL Myers, DC Sheppard, QT Phan, AA Sanchez, J E. Edwards, ... Cellular microbiology 7 (4), 499-510, 2005 | 232 | 2005 |
| Improvement in the outcome of invasive fusariosis in the last decade M Nucci, KA Marr, M Vehreschild, C De Souza, E Velasco, P Cappellano, ... Clinical Microbiology and Infection 20 (6), 580-585, 2014 | 200 | 2014 |
| The fungal exopolysaccharide galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps MJ Lee, H Liu, BM Barker, BD Snarr, FN Gravelat, Q Al Abdallah, ... PLoS pathogens 11 (10), e1005187, 2015 | 176 | 2015 |
| Novel inhalational murine model of invasive pulmonary aspergillosis DC Sheppard, G Rieg, LY Chiang, SG Filler, JE Edwards Jr, AS Ibrahim Antimicrobial agents and chemotherapy 48 (5), 1908-1911, 2004 | 176 | 2004 |
| CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy C Gavino, A Cotter, D Lichtenstein, D Lejtenyi, C Fortin, C Legault, ... Clinical infectious diseases 59 (1), 81-84, 2014 | 171 | 2014 |
| Role of Trehalose Biosynthesis in Aspergillus fumigatus Development, Stress Response, and Virulence N Al-Bader, G Vanier, H Liu, FN Gravelat, M Urb, CMQ Hoareau, ... Infection and immunity 78 (7), 3007-3018, 2010 | 171 | 2010 |
Scott G. FillerProfessor of Medicine, David Geffen School of Medicine at UCLABestätigte E-Mail-Adresse bei ucla.edu